Suchergebnisse - "Arnott, Clare"

PubPharm (9)

1

Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes

enthalten in: Kidney international | 2023

von Sen, T. | Ju, W. | Nair, V. | +12

2

The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus : A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials

enthalten in: Diabetes, obesity & metabolism | 2023

von Kang, A. | Smyth, B. | Neuen, B. | +16

3

Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension - the SaltSwitch Online Grocery Shopping randomized trial

enthalten in: American heart journal | 2022

von Maganja, D. | Trieu, K. | Reading, M. | +13

4

Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage : A post hoc mediation analysis of the CANVAS trial

enthalten in: Diabetes, obesity & metabolism | 2022

von Sen, T. | Koshino, A. | Neal, B. | +6

5

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure

enthalten in: Cardiovascular diabetology | 2022

von Tye, S. | Jongs, N. | Coca, S. | +7

6

Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes : A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials

enthalten in: Circulation | 2022

von Neuen, B. | Oshima, M. | Agarwal, R. | +17

CommentIn: Ann Intern Med. 2022 Sep;175(9):JC104. - PMID 36063558

7

Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients : a randomized, double-blind, controlled trial

enthalten in: The American journal of clinical nutrition | 2021

von Yu, J. | Thout, S. | Li, Q. | +10

CommentIn: Am J Clin Nutr. 2021 Jul 1;114(1):12-13. - PMID 33963732

8

Sodium-glucose co-transporter-2 inhibitors with and without metformin : A meta-analysis of cardiovascular, kidney and mortality outcomes

enthalten in: Diabetes, obesity & metabolism | 2021

von Neuen, B. | Arnott, C. | Perkovic, V. | +10

9

Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes : A systematic review and meta-analysis

enthalten in: Diabetes, obesity & metabolism | 2021

von Li, C. | Zhou, Z. | Neuen, B. | +14

1
[1]